AKBA
Akebia TherNASDAQ
Healthcare • Drug Manufacturers - Specialty & Generic
Updated 1 day ago
Coverage limited
Factor tilt: Anti-Momentum Micro Cap
$0.77-2.56%
Close Oct 13, 2026
- Market cap
- $206.56M
- 1 month
- -20.0%
- 3 months
- -44.2%
- 1 year
- -72.0%
- 52-week range
- $0.77$3.17
- Dividend
- No dividends on record
- Short interest
- 8.3% of float22.5M shares · settled Sep 30, 2026 · +9.6% since Sep 15, 2026 · FINRA
Fundamentals · trailing 12 months to Jun 30, 2026
- Revenue
- $219.06M
- Net income
- -$29.67M
- Free cash flow
- $40.23M
- Book value
- $25.02M
- Total debt
- $53.96M
- P/E
- —
- Price / sales
- 0.9×
- Price / book
- 8.3×
- FCF yield
- +19.5%
- Net margin
- -13.5%
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Portfolio context
Sign in to see your position size
We’ll show you if AKBA is in your portfolio and how much it contributes.
Sign inMarket context
Loading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
Smart money context
Holder IQ: MEDIUM
22 top institutions tracked
as of 2026-Q2 (filed 2026-09-22)
Last 13F trend: unchanged (light)
Unlock crowding heatmapUnlock filer discoveryInsider context
Sentiment: unknown
No recent insider trades detected.
Red flags: 0
Largest 13-F holders · Q2 2026
170 filers reported a long position in AKBA for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| BlackRock, Inc. | $22.8M | 20M | +6.9% |
| VANGUARD CAPITAL MANAGEMENT LLC | $12.9M | 11.3M | +1.4% |
| AQR CAPITAL MANAGEMENT LLC | $10.4M | 9.2M | +410.5% |
| GEODE CAPITAL MANAGEMENT, LLC | $7.7M | 6.7M | +4.3% |
| STATE STREET CORP | $6.1M | 5.4M | -53.6% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $4.9M | 4.3M | +894.5% |
| ACADIAN ASSET MANAGEMENT LLC | $4.6M | 4M | +190.8% |
| GOLDMAN SACHS GROUP INC | $4.2M | 3.7M | +2.4% |
| MILLENNIUM MANAGEMENT LLC | $3.6M | 3.2M | +34% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2.9M | 2.5M | +14.4% |
Get the Full Analysis for AKBA
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.